Clinical Trial Update: Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of cobicistat-boosted darunavir in HIV-infected adults has completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• Prezista (darunavir) (darunavir)
• Tybost (cobicistat) (cobicistat)

Snippet

Sponsor: Gilead Sciences | Conditions: Acquired Immunodeficiency Syndrome, HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2014-10-28